Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
Condition(s) studied
Investigational drug(s) / intervention(s)
Globe Mapping and Pulsed Field Ablation System (Globe PF System): During the procedure, the Globe Catheter will be delivered via standard femoral vein access and transseptal puncture. Anatomical and electrophysiological mapping of the left atrium (LA) will be followed by pulsed field ablation (PFA) to achieve pulmonary vein isolation (PVI). Additional PFA or radiofrequency (RF) ablation lesions may be created as deemed appropriate by the Investigator. Intracardiac electrogram mapping with the Globe PF System will be used to confirm PVI.
Study summary
The purpose of this study is to provide clinical data pertaining to the safety and performance of the Globe Mapping and Pulsed Field Ablation System for treating subjects with atrial fibrillation (AF).
Eligibility
Primary outcome measure(s)
- Rate of subjects presenting with primary safety events which are device- or procedure-related — up to 3-month visit
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Motol and Homolka University Hospital | Prague | Czechia | Recruiting |
More Kardium Inc. trials in Czechia
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05164107 on ClinicalTrials.gov ↗ ← All trials in Czechia